Raul R. Rodriguez

Raul R. Rodriguez is a declared insider of Rigel Pharmaceuticals Inc (chief executive), with filings sourced from SEC (Form 4). Between 17 August 2018 and 1 September 2026, the trades on record add up to 23 filings.

Both buying and selling appear: 2 purchases worth €912k, against 5 sales worth €282k. Purchases outweigh sales by €630k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 12 share grants and 4 option exercises.

Most recently, on 3 September 2026, the filings show a share grant worth €99k in Rigel Pharmaceuticals Inc. The most recent open-market purchase was published on 13 June 2022, 1,594 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.